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Rosemary (Rosmarinus officinalis — Labiatae) herb and oil are
commonly used as spice and flavoring agents in food processing for their
desirable flavor and high antioxidant activities (HO et al., 1994; LO et al.,
2002). Rosemary contains flavonoids, phenols, volatile oil and terpenoids
(NEWALL, 1996; COLLIN AND CHARLES, 1987).
Leaves of R. officinalis possess a variety of bioactivities; including
antioxidant (RICHEIMER et al., 1996), antitumor (SINGLETARY et al., 1996)
and anti-inflammatory actions (ALTINIER et al., 2007). These bioactivities
of the rosemary leaves extract are comparable with known antioxidants
constituents, such as carnosic acid, carnosol, rosemarinic acid, ursolic
acid, butylated hydroxyanisole and butylated hydroxytoluene, without the
cytotoxic and carcinogenic risk of synthetic antioxidants (HUANG et al.,
1994; RICHEIMER et al., 1996; RAMIREZ et al., 2006; ALMELA et al., 2006).
Among the antioxidant compounds in rosemary leaves, ~90 % of the
antioxidant activity can be attributed to carnosol and carnosic acid (LO et
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al., 2002). Recently, reports indicated that carnosol is active in anti-
inflammation and is an active anti-metastatic against malignant
melanocytes (HUANG, 2000; LO et al., 2002; PENG et al., 2007). Carnosol
was stated to inhibit nitric oxide (NO) production in activated
macrophages through modulation of the nuclear factor NF-á (CHAN et
al., 1995; Lo et al., 2002). Also, rosmarinic acid was widely studied for
its antimicrobial and complement inhibition properties (RAMPART et al.,
1986). Additional studies have revealed that rosemary extracts, carnosic
acid and carnosol strongly inhibited phase I enzyme, CYP 450 activities
and induced the expression of the phase II enzyme, glutathione S-
transferase (GST) (MACE et al., 1998). These results gave insight into the
different mechanisms involved in the chemopreventive actions of aqueous
rosemary leaves extract (RE).
Doxorubicin (DXR) is an anthracycline antibiotic used as an antitumor
agent against human malignancies such as leukemia, lymphomas and many
solid tumors (BOOSER AND HORTOBAGYI, 1994; PRAHALATHAN et al., 2006;
LEBRECHT et al., 2007). Though, previous investigations indicated that
DXR has the ability to induce mutations and chromosomal aberrations in
normal and malignant cells (SINGAL et al., 2000; JUNG AND RESZKA, 2001;
QUILES et al., 2002) in addition to a wide variety of toxic side effects on
organs including testis (YAGMURCA et al., 2004; PRAHALATHAN et al., 2006).
DXR was recognized to alter sperm development, production, structural
integrity and motility rates in association with increased cellular apoptosis
in spermatogonia and spermatocytes, induction of spermatid micronuclei
(SJOBLOM et al., 1998; KATO et al., 2001; KANG et al., 2002; SUOMINEN et
al., 2003; PRAHALATHAN et al., 2006) and oligozospermia (SAWADA et al.,
1994).
The cytotoxic action of DXR may be exerted by various mechanisms,
such as DNA binding, oxygen free radicals formation, membrane
composition differentiation and function alteration (ANTUNES and
TAKAHASHI, 1998; TAVARES et al., 1998; ANTUNES et al., 1999).
The reduction of oxidative DNA damage by antioxidants has been
evaluated as a chemotherapeutic approach for reducing damage caused
by chemotherapy agents such as doxorubicin (QUILES et al., 2002). So,
recent studies hypothesized that the combination of the chemotherapeutic
drug together with a potent antioxidant may be the appropriate approach
to reduce the toxic side effects of anticlastogenic agents. Though, some
properties of synthetic antioxidant drugs limited their therapeutic
application (YAGMURCA et al., 2004). Thus, the use of plant extracts and
food supplements which augment the major cellular endogenous
antioxidants following their administration have been recently preferred
to combat the oxidative stress associated with different diseases.
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Therefore, the present investigation was undertaken to 1) test the
anticlastogenic or clastogenic effects of aqueous rosemary leaves extract
(RE) on bone marrow and testis tissues of mice, 2) determine this extract
modulating effect on chromosomal damages, oxidative stress,
histopathological alterations and apoptosis induced by DXR and 3)
examine the dose-dependency of these effects.
MATERIALS AND METHODS
CHEMICALS — Doxorubicin (Adriblastina® produced by Carlo Erba)
was purchased from a local pharmacy in a form of 10 mg/ampoule. The
in situ cell death (TUNEL assay) detection kit was purchased from (POD;
Roche Molecular Biochemicals). All other chemicals were obtained from
Sigma (St. Louis, MO, USA).
ROSEMARY LEAVES EXTRACT PREPARATION — Rosemary leaves
(Rosmarinus officinalis) were obtained and identified at the Botany
Department, Faculty of Science, Beni-Sueif University. Leaves were
cleaned, shade dried, powdered and extracted. The extract was prepared
by refluxing leaves with bi-distilled H2O for 36 hours (12 hours X 3).
The cooled liquid extract was then transformed to powder by evaporating
its liquid contents. The powder was redissolved in bi-distilled water just
before oral administration (JINDAL et al., 2006).
 ANIMALS — 60 male albino mice (Mus musculus), aged 6 weeks and
weighing 28 g, were used. The animals were obtained from the
Ophthalmology Research Centre. They were housed in stainless-steel cages
at room temperature (25-30° C) and provided with food and water ad-
libitum.
DOSES AND TREATMENT — The dose of DXR in this study was selected
as 25 mg/kg body wt. This dose was previously reported to induce an
increase in the frequency of chromosomes, tissues and cells damage in
mammalian system (ANTUNES AND TAKAHASHI, 1998; PRAHALATHAN et al.,
2006). The animals were treated with DXR by the intraperitoneally (i.p.)
route since this mode of administration permits a marked exposure of
bone marrow and testis cells to the agent tested (PRESTON et al., 1987).
The chosen dose of DXR was adjusted 0.2 ml/25 g body wt in sterile
water prior to use and was given once after 15 days of the onset of the
experiment.
Four doses of rosemary leaves extract (25, 125, 250 and 375 mg/kg b.
wt.) were administrated prior to doxorubicin administration according to
the literature data (ARUOMA et al., 1992). Every dose was given one time/
three days by gastric incubation for 15 days.
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ORGANIZATION OF EXPERIMENTAL GROUPS — Experimental groups were
organized as 10 groups including 16 animals each. In each group ten
animals were used for cytogenetic analysis while the rest of animals (six
mice) were used for biochemical, histopathological and TUNEL analysis.
The animals of group one (G1) were used as a negative control group
treated with water. The animals of group two (G2) were served as positive
control and was pretreated with 0.2 ml of water one time/three days for
15 days before injection with a single i.p. dose  of DOX. In groups three,
four, five and six (G3, G4, G5 and G6) were orally given 25, 125, 250
and 375 mg/kg b. wt. of rosemary extract while those of G7, G8, G9 and
G10 were pretreated with 25, 125, 250 and 375 mg/kg b. wt. of rosemary
extract respectively, one time/three days for 15 days before DOX treatment
(ARUOMA et al., 1992) which was given two hours after the last dose of
RE as a single i.p. dose of 25 mg/kg b. wt.
PREPARATION OF THE MICE BONE MARROW CELLS — Bone marrow cell
preparations for the analysis of chromosomal aberrations and mitotic
indices were conducted by the colchicine–hypotonic technique.After
completion of the treatment period, five animals from each group were
scarified 24 h and 48 h post-injection with H2 O, DXR or RE, by cervical
dislocation. Colchicine was given at the dose of 4 mg/Kg b.wt.
intraperitoneally at 22 and 46 h prior to sacrificing the animals. The bone
marrow smears of animals in each group were prepared according to
PRESTON et al. (1987). For each group, slides were stained with Giemsa
staining method and 50 well spread metaphase plates/animal were analyzed
for chromosomal aberrations and the incidence of aberrant cells. The
mitotic index was obtained by counting the number of mitotic cells in
1000 cells/animal. The percentage of suppressed aberrant cells was
calculated according to SHUKLA & TANEJA, (2002) as follows: 100 – [% of
aberrant cells in G7-G10 / % aberrant cells in G2 (positive control group)]
x 100.
BIOCHEMICAL ANALYSIS — A part of testis (0.5 g) was ice-cooled and
homogenized in 5 ml 0.9 % NaCl (10 % w/v) using Teflon homogenizer
(Glas-Col, Terr Haute, USA). The homogenate was centrifuged at 30000
g for 15 minutes at 4° C. The supernatant was collected and preserved at
-20° C till used for oxidative stress and antioxidant defense system
measurements. In testes homogenates, lipid peroxidation (LPX) was
determined by measuring the thiobarbituric acid reactive substances
(TBARS) according to method of PRESSUS et al. (1998). Superoxide
dismutase (SOD) activity was measured in the first supernatant part
according to the method of Arthur and BOYNE (1985). Glutathione reduced
form (GSH) level was measured colourmetrically as protein-free sulfhydryl
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content using Ellman reagent (BEUTLER et al., 1963). Catalase (CAT)
activity was analyzed according to the method of COHEN et al. (1970) by
monitoring the enzyme-catalyzed decomposition of hydrogen peroxide
using potassium permanganate. Glutathione peroxidase (GPX) was
assayed according to the method of PINTO AND BARTLEY (1989).
On the other hand, Blood samples were obtained from cervical vein
and allowed to coagulate at room temperature. Sera were separated by
centrifugation at 3000 r.p.m. for 15 minutes. The clear non haemolysed
sera were quickly removed and stored in deep freezer at -40ºC till being
used for testosterone measurements. Serum testosterone level was
measured by radioimmunoassay (RIA) as described in the instructions
provided with the assay kits (Diagnostic Products Corporation, USA).
HISTOPATHOLOGICAL AND TUNEL STUDIES — Pieces of testis were
fixed in 10% neutral buffered formalin for 24 hours. After dehydration,
tissue samples were embedded in paraffin wax, sectioned at 5 µm and
stained with haematoxylin and eosin (BANCROFT & GAMBLE, 2002) for
histopathological examination, or mounted on super-frost plus slides
(Thermofisher Scientific, Pittsburg, PA) to detect apoptotic cells using
the TUNEL technique (NEGOESCU et al., 1996). Haematoxylin and eosin-
stained paraffin sections of testes were also examined to determine the
relative percentages of different germ cell types in 10 seminefrous tubules/
animal for six animals/ group. The Tdt-mediated dUT nick-end labeling
(TUNEL) assay was applied using the in situ cell death detection kit
(POD; Roche Molecular Biochemicals) according to the manufacturer
instructions. The apoptotic index (the percentage of dark brown to black-
stained cells) was determined at 10-random locations within each
seminefrous tubule. Ten seminefrous tubules for each animal were recorded
for six animals/ group.
STATISTICAL ANALYSIS — Statistical analyses for the difference in the
mean number of chromosomal aberrations and mitotic indices between
groups were obtained by using student-t-test (P < 0.05 was considered
significant) while the biochemical and the immunohistochemical results
were analyzed using PC-STAT one-way analysis of variance (RAO et al.,
1985).
RESULTS
According to the cytogenetic results illustrated in tables 1, 2 and 3, six
structural and numerical chromosomal aberrations were determined in
the control and the experimental groups. The results, in first phases of the
cell cycle (24 h sampling time), revealed that doxorubicin (DXR) when
given at a single dose of 25 mg/kg b. wt. (G2) caused a high frequency of
chromosomal aberrations in bone marrow cells of mice when compared
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with the control (G1) group. The chromatid breakages were the most
frequent chromosomal aberration. Other structural and numerical
aberrations increased significantly at P <0.05 over the control group (G1),
while the mitotic index decreased significantly to 47.28, compared to the
control value of 82.84 (P <0.05), indicating bone marrow cytotoxicity
(Table 3). When the aqueous rosemary extract (RE)-treated groups (G3,
G4, G5 and G6) were compared with the control group (G1) in terms of
the mean total number of chromosomal aberrations per cell and percentage
of incidence of aberrant cells, the G3, G4, G5 and G6 groups displayed
no significant differences (P > 0.05), Confirming its non- mutagenicity
(Table 3). The mean total numbers of structural and numerical
chromosomal aberrations increased gradually with increasing the dose of
RE (Tables 1 & 2). The RE was also found to be non-cytotoxic at the
given four doses (25, 125, 250 and 375 mg/kg b. wt.) as indicated by the
low significant decrease in the mitotic index from that of G1 and its
significant increase over G2 (Table 3).
In DXR groups pretreated with RE (G7, G8, G9 and G10), data
obtained during first phase of cell cycle (24 h sampling time), revealed a
significant decrease in rates of clastogenetic changes compared with the
DXR treated group (Table 1 & 3). All types of chromosomal aberrations
induced by DXR including chromatid breakages (breaks or clear terminal
deletion), end to end association, centric fusion, centromeric attenuation,
and other multiple damages were found to be reduced by RE. Also, doses
of 25, 125, 250 and 375 mg/kg b. wt. of RE increased the status of the
mitotic index to 59.25, 64.14, 56.15 and 53.07, respectively, indicating
its anti-cytotoxicity towards DXR (Table 3). The percentage of aberrant
cells in DXR-treated animals (45.60 %) was reduced to 27.60 %, 30.00
%, 36.00 % and 37.20 % (P < 0.05) by 25, 125, 250 and 375 mg/kg b.
wt. dose of RE, respectively (Table 3). A decrease in the number of
aberrations per cell was also observed in RE pretreated and DXR post-
treated groups. The calculated suppressive effect was 39.474 %, 34.211
%, 21.053 % and 18.421 % by 25, 125, 250 and 375 mg/kg b. wt. of RE,
respectively (Fig. 1).
During the second phase of the cell cycle (48 h sampling time) the
incidence of different types of chromosomal damage caused by DXR
declined at all four dose levels of RE pre-treatment (Tables 2 & 3). The
incidence of aberrant cells percentage was found to be 42.00 in G2 and
declined to 33.20, 30.00, 31.60 and 32.80 (P < 0.05) in G7, G8, G9 and
G10, respectively (Table 2). Mitotic indices of these groups when compared
with that of DXR-treated group (G2), were found to be increased to 63.30,
65.27, 54.87 and 60.51 (P < 0.05) in groups G7, G8, G9 and G10,
respectively (Table 3). The inhibition efficacy using 25, 125, 250 and
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375 mg/kg b. wt. of RE pretreatment against DXR-induced cytogenetic
damage was 20.952 %, 28.571%, 24.762 % and 21.905 %, respectively
(Fig. 1).
  Concerning the histopathological, biochemical and the apoptotic index
investigations, the histological examination of the testes of animals in
DXR-treated group (G2) showed that DOX treatment disrupted the cellular
architecture of the normal testicular tissues (Fig. 2a and 2b) . The
somniferous tubules showed decreased cellularity, drastic reduction in
tubular diameter accompanied by atrophy evidenced by the appearance
of cytosolic vacuoles, and apical sloughing and shedding of the cellular
material in the lumen. The epithelium was disorganized resulting in
increased inter-tubular spaces and the basement membrane became
irregular and folded (Fig. 2b). In addition, the number of the intact leydig
cells was reduced and the cells were almost atrophied (Table 4). Moreover,
a significant depletion in the number of all tubular cell populations was
noticed except for the secondary spermatocytes which showed significant
elevation. The transformation of spermatogonia to spermatocytes (4C/
2C ratio) was also significantly reduced (Table 4). This drop was
accompanied by extensive DNA degradation (Fig. 3b, Table 5) represented
by a significant increased incidence of apoptotic cells (TUNEL-positive
cells) compared to the negative (distilled water) control (Fig. 3a) and
aqueous rosemary extract (G3, G4, G5 and G6) groups (Figs. 3c, d, e
and f). Spermatogonia and spermatocytes appeared the target of DXR-
induced DNA damage.
Also, DXR induced a highly significant increase (P< 0.001) in the
level of lipid peroxidation and the activity of superoxide dismutase while
the activities of the other antioxidant enzymes such as glutathione
peroxidase, catalase and glutathione reduced form were significantly
declined (P< 0.001). The ratio of dismutase to glutathione peroxidase
and/or catalase was significantly increased (Table 5).
 Furthermore, the serum level of testosterone was found to be
significantly reduced in doxorubicin-injected group (G2) respective to
the negative control group and aqueous rosemary extract groups (Table
5).
Pre-treatment with all doses of aqueous rosemary extract of DXR-
injected mice (G7, G8, G9 and G10) ameliorated the histopathological
lesions, activated leydig cells proliferation (decreased intertubular spaces)
(Figs. 2g, h, i and j), increased the transformation rate of spermatogonia
to spermatocytes (4C/2C ratio) and the primary spermatocytes to
spermatids and sperms (Table 4).
Furthermore, these doses of aqueous rosemary extract declined the
DNA damage (the germ cell apoptotic index) (Figs. 3g, h, i and j, Table
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Fig. 1: The suppressive effect of aqueous rosemary leaves extract (RE) in bone marrow cells of mice
at sampling times 24 and 48 hours.
Table 1. Suppressive effect of RE preteated on DXR induced structural and numerical chromosomal
aberrations in mouse bone marrow cells at 24 h sampling time.
 
Values in brackets represent mean + SE /animal.                              a Chromatid breakage includes chromatid breaks or terminal clear deletions 
b Significantly different from untreated controls (G1) P < 0.05.           c Significantly different from positive controls (G2) P < 0.05. 
Structural Chromosomal Aberrations  Numerical Chromosomal Aberrations  
 
Groups 
 
 
Number 
of  
examined 
cells  
 
Chromatid a 
Breakage 
 
Centric  
Attenuation 
 
Centric 
Fusion 
 
End to end 
Association 
 
Total of 
Structural 
Aberrations 
Number of 
cells with 
one aberr. 
Number of 
cells with 
more than 
one aberr. 
 
Polyploidy 
 
Endomitosis 
 
Total of 
Numerical 
Aberrations 
G1 250 18 
(3.60+1.200) 
2 
(0.40+0.489) 
1 
(0.20+0.400) 
2 
(0.40+0.489) 
23 
(4.60+1.356) 
23 
 
--- --- 8 
(1.60+0.489) 
8 
(1.60+0.489) 
G2 250 82 b 
(16.40+3.006) 
1 
(0.20+0.400) 
15 b 
(3.00+0.632) 
12 b 
(2.40+1.200) 
110 b 
(22.00+2.366) 
64 
 
46 
 
6 b 
(1.20+0.748) 
20 b 
(4.00+1.549) 
26 b 
(5.20+1.166) 
G3 250 22 
(4.40+2.245) 
7 b 
(1.40+1.020) 
--- 1 
(0.20+0.400) 
30 b 
(6.00+2.898) 
27 
 
3 
 
--- 11 
(2.20+0.979) 
11 
(2.20+0.979) 
G4 250 22 
(4.40+1.019) 
10 b 
(2.00+1.095) 
--- --- 32 b 
(6.40+1.019) 
30 
 
2 
 
2 
(0.40+0.800) 
4 
(0.80+0.400) 
6 
(1.20+0.979) 
G5 250 26 b 
(5.20+2.315) 
4 
(0.80+0.748) 
3 
(0.60+0.489) 
1 
(0.20+0.400) 
34 b 
(6.80+2.993) 
27 
 
7 
 
2 
(0.40+0.489) 
9 
(1.80+0.400) 
11 
(2.20+0.400) 
G6 250 31 b 
(6.20+1.166) 
5 
(1.00+0.894) 
2 
(0.40+0.489) 
2 
(0.40+0.489) 
40 b 
(8.00+1.095) 
36 
 
4 
 
4 
(0.80+0.979) 
9 
(1.80+0.748) 
13 
(2.60+1.625) 
G7 250 60 c 
(12.0+2.000) 
--- 5 c 
(1.00+0.632) 
4 c 
(0.80+0.748) 
69 c 
(13.80+1.720) 
59 
 
10 
 
7 
(1.40+1.019) 
7 c 
(1.40+0.800) 
14 c 
(2.80+1.166) 
G8 250 61 c 
(12.20+1.900) 
3 
(0.60+0.489) 
5 c 
(1.00+0.632) 
5 c 
(1.00+0.000) 
74 c 
(14.80+2.039) 
67 
 
7 
 
2 c 
(0.40+0.489) 
9 c 
(1.80+1.326) 
11 c 
(2.20+1.166) 
G9 250 52 c 
(10.40+1.959) 
1 
(0.20+0.400) 
12 
(2.40+0.489) 
4 c 
(0.80+0.979) 
69 c 
(13.80+2.856) 
61 
 
8 
 
6 
(1.20+1.166) 
20 
(4.00+1.414) 
26 
(5.20+1.166) 
G10 250 69 c 
(13.80+2.039) 
--- 7 c 
(1.40+0.800) 
4 c 
 (0.80+0.748) 
80 c 
(16.00+1.673) 
66 
 
14 
 
6 
(1.20+0.979) 
14 c 
(2.80+1.469) 
20 c 
(4.00+1.265) 
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Table 2. Suppressive effect of RE preteated on DXR induced structural and numerical chro-
mosomal aberrations in mouse bone marrow cells at 48 h sampling time.
Table 3. Effect of aqueous rosemary extract on mitotic index, incidence of aberrant cells,
number of aberrations/cell and percentage of suppressed aberrant cells in doxorubicin-injected
mice.
 
 
Values in brackets represent mean + SE /animal.                              a Chromatid breakage includes chromatid breaks or terminal clear deletions. 
b Significantly different from untreated controls (G1) P < 0.05.           c Significantly different from positive controls (G2) P < 0.05. 
Structural Chromosomal Aberrations  Numerical Chromosomal Aberrations  
 
Groups 
 
 
Number 
of  
examined 
cells  
 
Chromatid a 
Breakage 
 
Centric  
Attenuation 
 
Centric 
Fusion 
 
End to end 
Association 
 
Total of 
Structural 
Aberrations 
Number of 
cells with 
one aberr. 
Number of 
cells with 
more than 
one aberr. 
 
Polyploidy 
 
Endomitosis 
 
Total of 
Numerical 
Aberrations 
G1 250 18 
(3.60+0.800) 
2 
(0.40+0.489) 
--- 2 
(0.40+0.489) 
22 
(4.40+1.356) 
22 
 
--- 2 
(0.40+0.800) 
8 
(1.60+0.489) 
10 
(2.00+1.095)
G2 250 89 b 
(17.80+5.912) 
9 b 
(1.80+1.469) 
7 b 
(1.40+0.489) 
7 b 
(1.40+0.489) 
112 b 
(22.20+5.192) 
87 
 
25 
 
8 b 
(1.60+0.800) 
14 b 
(2.80+2.785) 
22 b 
(4.40+2.870)
G3 250 22 
(4.40+1.356) 
7 b 
(1.40+1.020) 
--- 1 
(0.20+0.400) 
30 b 
(6.00+2.457) 
27 
 
3 
 
1 
(0.20+0.400) 
11 
(2.20+0.768) 
12 
(2.40+1.170)
G4 250 21 
(4.20+1.391) 
10 b 
(2.00+1.120) 
--- --- 31 b 
(6.20+1.213) 
28 
 
3 
 
--- 6 
(1.20+0.748) 
6 
(1.20+0.748)
G5 250 26 b 
(5.20+1.166) 
5 
(1.00+0.894) 
3 
(0.60+0.489) 
2 
(0.40+0.800) 
36 b 
(7.20+1.691) 
27 
 
9 
 
2 
(0.40+0.489) 
10 
(2.00+1.120) 
12 
(2.40+1.200)
G6 250 30 b 
(6.00+2.898) 
6 b 
(1.20+0.456) 
--- 4 
(0.80+0.979) 
40 b 
(8.00+1.095) 
30 
 
10 
 
5 
(1.00+0.800) 
9 
(1.80+0.487) 
14 
(2.80+2.246)
G7 250 68 c 
(13.60+2.939) 
1 c 
(0.20+0.400) 
7 
(1.40+0.489) 
9 
(1.80+1.166) 
85 c 
(17.00+2.449) 
73 
 
12 
 
6 
(1.20+0.748) 
4 c 
(0.80+0.979) 
10 c 
(2.00+1.095)
G8 250 65 c 
(13.60+1.496) 
--- 3 c 
(0.60+0.800) 
8 
(1.60+0.489) 
76 c 
(15.80+1.600) 
64 
 
12 
 
2 c 
(0.40+0.800) 
10 c 
(2.00+2.280) 
12 c 
(2.40+2.059)
G9 250 53 c 
(10.60+1.356) 
--- 3 c 
(0.60+0.800) 
3 c 
(0.60+0.489) 
59 c 
(11.80+0.979) 
52 
 
7 
 
4 c 
(0.80+1.166) 
17 
(3.40+1.019) 
21 
(4.20+1.469)
G10 250 65 c 
(13.00+2.097) 
1 c 
(0.20+0.400) 
7 
(1.40+1.019) 
1 c 
(0.20+0.400) 
74 c 
(14.60+2.416) 
65 
 
9 
 
5 
(1.00+1.265) 
9 c 
(1.80+1.166) 
14 c 
(2.80+1.782) 
Mitotic Index a Incidence of aberrant cells a (%) Number of aberrations/Cell a Suppressive effect  
(%) 
 
Groups 
24hrs 48hrs 24hrs 48hrs 24hrs 48hrs 24hrs 48hr
G1 82.839 + 5.977 83.752 + 4.859 12.40 + 1.496 12.80 + 2.993 0.0250 + 0.003 0.0260 + 0.006 --- --- 
G2 47.28 + 9.294 b 47.51 + 5.641b 45.60 + 3.441 b 42.00 + 6.324 b 0.556 + 0.091 b 0.528 + 0.118 b --- --- 
G3 68.51 + 4.566 66.60 + 3.748 b 13.20 + 4.489 14.30 + 4.070 0.164 + 0.071 0.166 + 0.062  --- --- 
G4 68.48 + 4.084 b 67.10 + 3.745 b 14.80 + 2.713 14.00 + 2.412 0.152 + 0.032 0.150 + 0.031  --- --- 
G5 65.80 + 4.014 b 65.35 + 3.504 b 15.60 + 4.800 15.40 + 4.119 0.180 + 0.065 0.191 + 0.066  --- --- 
G6 64.77 + 2.805 b 68.22 + 2.658 b 20.20 + 3.487 19.40 + 2.490 0.212 + 0.034  0.216 + 0.041  --- --- 
G7 59.25 + 4.433 c 63.30 + 4.792 c 27.60 + 4.271 c 33.20 + 3.919 c 0.333 + 0.048 c 0.384 + 0.046 c 39.474 20.952 
G8 64.14 + 2.391c 65.27 + 4.420 c 30.00 + 3.347 c 30.00 + 4.000 c 0.340 + 0.049 c 0.360 + 0.063 c 34.211 28.571 
G9 56.15 + 4.483 54.87 + 5.253 36.00 + 3.347 c 31.60 + 1.959 c 0.388 + 0.041 c 0.340 + 0.022 c 21.053 24.762 
G10 53.07 + 4.228 60.51 + 1.079 c 37.20 + 4.118 c 32.80 + 3.487 c 0.424 + 0.034 c 0.356 + 0.034 c 18.421 21..905 
  
a Values represent mean + SE of five animals. 
b Significantly different from untreated controls (G1) P < 0.05. 
c Significantly different from positive controls (G2) P < 0.05. 
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Table 4. Effects of aqueous rosemary leaves extract on testicular cell population dynamics of
doxorubicin-treated animals.
Table 5. Effects of aqueous rosemary leaves extract on oxdative stress parameters, antioxidante
defense system, testosterone and apoptotic index  in dosorubicin-injected mice.
 
Data are expressed as mean ± standard error. 
For each parameter, values sharing the same superscri t letter are not statistically significant. 
 
 
 
Interstitial cells  Germ cell types 
Degenerating 
Leydig cells 
Intact leydig cells 4C/2C 
ratio 
Spermatids and sperms 
(1C) 
Secondary  
spermatocytes 
(S-phase) 
Primary spermatocytes 
(4C) 
Spermatogonia 
(2C) 
 
 
Groups 
15.25±0.02i 81.3±0.23ab 0.81± 0.01ab 65.37±0.12b 10.44±0.09g 11.55±0.13c 14.11± 0.04d G1 
45.77±0.28a 52±0.82e 0.68± 0.01e 44.18±0.05g 30.45±0.12a 8.48±0.11d 12.56 ± 0.12f G2 
21.27±0.13f 77.7±0.61abc 0.77± 0.03d 63.41±o.16c 10.46±0.14g 9.34±0.14d 12.19±0.16g G3 
13.37±0.14j 86.3±0.23a 0.80± 0.07bc 66.41±0.12a 12.45±0.12e 12.43±0.09c 17.33±0.16c G4 
18.3±0.11h 81.7±0.24ab 0.78± 0.01cd 65.39±0.13b 12.27±0.06e 11.39±0.13c 13.43±0.11e G5 
20.2±0.14g 81±0.69ab 0.81± 0.01ab 65.08±0.54b 11.38±0.13f 10.81±0.16d 13.38±0.18e G6 
31.37±0.14b 68±0.41d 0.67± 0.02e 50.04±0.17f 12.26±0.09e 12.2±0.18d 18.16±0.11b G7 
22.23±0.10e 78±0.41abc 0.83± 0.02a 56.47±0.37d 19.40±0.16b 16.43±0.13a 19.36±0.11a G8 
23.57±0.2d 74.6±0.23bcd 0.81± 0.02ab 51.87±0.13e 17.38±0.12c 14.42±0.14b 18.41±0.11b G9 
28.17±0.27c 71±0.41cd 0.69± 0.01e 50.13±0.55f 13.56±0.16d 12.56±0.18c 18.28±0.09b G10 
< 0. 001 < 0. 001 < 0. 001 < 0. 001 < 0. 001 < 0. 001 < 0. 001 F-probability 
0.711 9.41 0.002 0.841 0.346 1.59 0.356 LSD at 5% 
0.970 12.84 0.003 1.133 0.466 2.15 0.479 LSD at 1% 
 
Data are expressed as mean ± standard error. 
For each parameter, values sharing the same superscri t letter are not statistically significant. 
LPX: lipid peroxidation            GSH: Glutathione r duced form          GPX: Glutathione peroxidase        CAT: Catalase               SOD: Superoxide dismutase  
 
Oxidative stress and antioxidant defense system parameters  
 
Groups  
LPX 
 
GSH 
 
GPX 
 
CAT SOD 
 
 
SOD/ GPX 
 
 
SOD/CAT 
Testosterone 
(ng/mol) 
 
Apoptotic 
index 
G1 33.63±0.31i 42.38±0.65a 152.033±0.03g 33.18±0.28abc 283.7 ± 1.13d 1.78±0.02e 8.5±0.02h 3.37±0.06a 2.78±0.03g 
G2 53.81±0.18a 32.84±0.98d 112.9±2.5f 23.34± 0.25e 398.65±0.98a 3.3±0.06a 17.01±0.07a 1.3±0.04c 39.1±0.27a 
G3 37.67±0.21g 34.31±0.78d 128.49±0.69abc 27.09± 0.28d 316.98±1.09bcd 2.38±0.08b 11.45±0.08b 2.6±0.04b 2.2±0.04c 
G4 45.73±0.27c 42.26±0.57a 174.49±0.89a 36.14± 0.18a 345.05±2.1b 1.85±0.02de 9.3±0.07f 3.43±0.02a 3.2±0.1f 
G5 42.89±0.25d 37.0±0.97b 155.39±1.02b 35.14± 0.22ab 334.79±0.77bc 2.3±0.05bc 9.38±0.14ef 3.4±0.11a 2.56±0.02gh 
G6 39.29±0.18f 36.03±0.48c 134±0.55d 34.21± 0.29acd 326.41±1.02bcd 2.35±0.05b 8.9±0.04g 2.63±0.15b 2.45±0.02gh 
G7 34.17±0.24i 32.11±0.45d 125.43±0.9e 30.74± 0.22bcd 292.4±1.06cd 2.2±0.09bc 9.8±0.03c 2.47±0.12b 27.5±0.09b 
G8 44.17±0.11c 41.61±0.22a 155.12±1.02b 34.45± 0.13ab 323.38±0.74bcd 1.9±0.05d 9.1±0.06fg 3.1±0.04a 20.5±0.08e 
G9 41.28±0.27e 37.67±0.64b 144.34±0.68c 32.17± 0.24abc 313.41±0.51bcd 2.17±0.01c 9.6±0.05cd 2.57±0.06b 23. 5±0.04d 
G10 36.39±0.24h 33.88±2.6cd 132.19±0.65d 31.12± 0.18bcd 303.22±0.6bcd 2.23±0.06bc 9.5±0.08de 2.5±0.06b 24.63±0.1c 
F-probability < 0. 001 < 0. 001 < 0. 001 < 0. 001 < 0. 001 < 0. 001 < 0. 001 < 0. 001 < 0. 001 
LSD at 5% 0.65 2.9 5.3 4.9 45.8 0.16 0.21 0.3 0.4 
LSD at 1% 0.88 3.9 7.1 
 
6.7 
 
61.76 
 
0.21 
 
0.28 
 
0.4 
 
0.6 
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Fig. 2 [a-f].  Photomicrographs of  haematotoxylin and eosin-stained testis sections. X 165 — a, illustrating
the normal control testicular histological structure; the seminefrous tubules (ST) with their lumen (LU), the
interstitial cells (IC) in the tubular spaces, the spermatogenic lineages and the Sertoli cells (“!); b, showing
atrophied seminefrous tubules (ST) after doxorubicin injection with severe destruction of the spermatogenic
lineage and tubular vacuolations (V). Some tubules showed great reduction of sperms in the lumen (*), vacuolar
degenerative changes of spermatogonia (VS) and great reduction in their size; c, indicating normal seminefrous
tubules with their lumen (LU), spermatogenic lineage and Sertoli cells (“!) recorded in low dose (25 mg/ kg
b. wt) rosemary leaves aqueous extract treated group. Note the interstitial cells (IC); d, illustrating normal
histological structure of a testis of mice administered 125 mg/ kg b. wt. of the aqueous rosemary extract. Note:
The lumen (LU) is occupied with numerous sperms (“!); e, showing hyperplastic interstitial cells (IC) and
normal seminefrous tubules in the testes of mice given 250 mg/kg b. wt of the rosemary aqueous extract; f,
illustrating reduction in spermatogenic lineage recorded in the 375 mg/kg b. wt. rosemary leaves aqueous
extract-treated group.
46 Acta Biol. Par., Curitiba, 38 (1-2): 35-57. 2009.
Fig. 2. [g-j]. Photomicrographs of  haematotoxylin and eosin-stained testis sections. X 165 —  g, showing
vacuolar degenerative changes in spermatogonia (!) associated with reduction in the spermatogenic lineage
and sperms recorded in the doxorubicin-injected mouse administered the low dose (25 mg/ kg b. wt.) of the
aqueous rosemary extract; h, indicating normal testicular structure, observed in mice treated with aqueous
rosemary leaves extract (125 mg/kg b. wt.) before doxorubicin administration; i, illustrating some normal
seminefrous tubules and others (*) suffering from great reduction in the spermatogonia, reported after
administration of the aqueous rosemary leaves extract in a dose of 250 mg/kg b. wt. prior to doxorubicin
injection. Note the clumps of sperms (“!); j, showing vacuolar degenerative changes of spermatogonia (!),
recorded in doxorubicin-pretreated group with the high dose of the aqueous rosemary leaves extract in a dose
of 375 mg/kg b. wt.
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Fig. 3 [a-j]. Photomicrograph of TUNEL-stained testis sections indicating: a, the apoptotic
index variability (dark-brown nuclei) recorded in the testis sections among the control
group; b, the doxorubicin-injected group, c, d e and f, the rosemary aqueous extract-treated
groups with 25, 125, 250 and 375 mg/ kg b. wt. (c, d, e and f), respectively  and the treated
groups with 25, 125, 250; and g, h, i and j, 375 mg/ kg b. wt. of rosemary aqueous extract
prior to doxorubicin administration, respectively.  [X 165].
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5), reversed the alterations in androgenesis (testosterone level) (Table 5)
and increased the number of intact leydig cells (Table 4) as compared to
the doxorubicin group.
These doses, also, reduced lipid peroxidation and superoxide dismutase
levels and increased the activity of catalase, glutathione peroxidase and
reduced glutathione relative to the doxorubicin group (Table 5). The ratio
of SOD/catalase or peroxidase was nearly returned to the control value.
DISCUSSION
Numerous investigations indicated that, some plant natural product
extracts may protect from harmful oxygen species and free   radicals on
electrophiles intermediates of anticancer drugs, which damage DNA and
other cell targets (ANTUNES et al., 1999; SHUKLA & TANEJA, 2002). Some
of these protection studies have shown beneficial effects of these extracts
against DXR toxicity (CABRERA, 2000; QUILES et al., 2002).
Doxorubicin (DXR) is an antineoplastic drug which is cell cycle specific
for the S phase of cell division (KUSYK & HSU, 1976). The majority of the
mutagenic/carcinogenic compounds act by generating electrophillic
intermediates by cellular enzymatic reactions causing mutagenic and
cytotoxic effects. However, several mechanisms seemed to account for
the effects of the anthracycline; doxorubicin both in term of anticancer
action and other organ toxicities (DIEMER et al., 2003; GÜLKAÇ et al.,
2004). DXR cytotoxicity and genotoxicity may be mediated by free radicals
derived from this drug and its capability to induce apoptosis through a
wide variety of mechanisms including production of reactive oxygen
species (ROS), alkylation of cellular macromolecules, DNA intercalation
and cross-linking, lipid peroxidation, cell membrane damage, ceramide
production and p53 induction in various tissues (BOSE et al., 1995;
LORENZO et al., 2002; QUILES et al., 2002; ASHIKAWA et al., 2004). Previous
studies also, indicated the DXR effect on reproductive performance, and
attributed this effect to the destruction of meiotic and early spermatogenic
stages (MEISTRICH et al., 1985; OZAKI et al., 1989; KATO et al., 2001).
The present study indicated that animals treated with a single dose of
DXR showed several-folds increase in the frequency of aberrant cells,
decrease in mitotic index, too high ratio of dismutase to glutathione
peroxidase and/ or catalase, low serum levels of testosterone, inhibition
of primary spermatocytes transformation to spermatids and increased DNA
damage (apoptotic index). This agrees with the previous investigations
which reported the ability of DXR to react with electron rich areas of
susceptible molecules such as nucleic acid and proteins (Barton et al.,
2003). Therefore, DXR was suggested to target rapidly dividing cells,
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disrupting cell growth, mitotic activity, differentiation, and elevate the ratio
of dismutase to glutathione peroxidase and/ or catalase which lead to
increased H2O2 concentration (ANDERSON et al., 1995; SHINODA et al.,
1999; MIZUTANI et al., 2005; MISHRA & BHIWGADE, 2007).
In the current study, administration of aqueous rosemary extracts abated
the oxidative stress, chromosomal damages, histopathological lesions and
apoptosis produced by doxorubicin toxicities via decreasing the incidence
of aberrant cells, increasing mitotic index, elevating antioxidant enzymes
like GSH, CAT, GPX, lowering the SOD/ GPX or SOD/ catalase ratio,
decreasing extensive DNA damage (apoptotic index), diminishing lipid
peroxidation, reversing the tubular cell populations’ ratio to the control
distribution or repairing the androgenesis.
Previous studies investigated the antioxidant efficiency and the
anticytotoxic effect of RE. The current results are in accordance with
those of NUSIER et al. (2007) who reported that no significant changes in
testicular cell population dynamics, sperm dynamics and testosterone level
of male rats treated with aqueous extract of rosemary at a dose of 250
mg/kg b. wt., respective to the control group. But adverse effects on all
preceding variables were recorded at the dose of 500 mg/kg b. wt. Also,
SERDAROGLU & YILDIZ-TURP (2004) reported that rosemary extract slow
down effectively the lipid peroxidation in chicken. Moreover, LO et al.
(2002) reported that carnosol, a naturally occurring phytopolyphenol found
in rosemary leaves, showed a potent antioxidative activity against á, á-
diphenyl-ß-picrylhydrazyl (DPPH) free radicals produced from Fenton
reaction.
BASAGA et al. (1997) attributed the antioxidant activity of rosemary
extract to its constituents of phenolic compounds. Also, earlier studies
implicated its antimutagenic, anti-inflammatory and antioxidant effects
to the presence of carnosic acid, carnosol, rosemarinic acid, ursolic acid,
butylated hydroxyanisole and butylated hydroxytoluene compounds
(ALMELA et al., 2006; RAMIREZ et al., 2006; CHANG et al., 2008). The
mechanisms for protection of RE phenolic compounds involves scavenging
potentially toxic and mutagenic electrophiles and free radicals that
modulate activation of extra-cellular signaling protein, tumor necrosis
factor (TNF), a major mediator of apoptosis and inflammatory response
and enhance high antioxidative activity pathways (CHEN and GOEDDEl,
2002; LO et al., 2002; JANG et al., 2007). It has been reported that the
antioxidant activity of such RE phenolic compounds was related to their
hydroxyl group in addition to the presence of a second hydroxyl group in
the ortho or para position which is known to increase the antioxidative
activity due to additional resonance stability (HO et al., 2000). Carnosic
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acid, carnosol and rosmarinic acid have o-hydroxyl group and possessed
high antioxidative activity.
In conclusion, the present results demonstrated that 125 mg/kg b.wt.
was the most potent dose of the aqueous rosemary leaves extract in
significantly decreasing the chromosomal aberrations, increasing the
mitotic index, reducing the DNA damage (apoptotic index), improving
the histopathological lesions, decreasing the oxidative stress marker (lipid
peroxidation), increasing the antioxidant enzymes activities of catalase,
glutathione peroxidase and glutathione reduced form, raising the serum
testosterone level and shifting the germ cell transformation ratio towards
the negative control value. In Contrary, the less effective dose of this
extract on the preceding parameters was the lowest dose (25 mg/kg. b.
wt). The higher two doses (250, 375 mg/kg. b. wt) showed more or less
similar effects but are of higher efficacy than the lowest.
RESUMO
O estudo (em rato) demonstrou a eficácia da utilização do extrato
aquoso das folhas de alecrim na redução da taxa de aberrações
cromossômicas e na divisão mitótica resultante da utilização de
doxorobicina sobre a medula óssea. Também na melhora das mudanças
celulares, na diminuição da "morte programada" e da taxa de SOD/CAF'
SOD/GPX nos testículos dos ratos.  Igualmente, o tratamento afetou a
taxa de modificação das células espermáticas, o aumento do hormônio
testosterona, e a taxa das enzimas anti-oxidantes como a CAT' GPX'
GSF, em comparação com os animais injetados apenas com doxorobicina.
A dose de 125 mg/kg de peso corpóreo, é a mais adequada para melhorar
a sobrevida.
PALAVRAS CHAVE: doxorubicina; citogenética; histopatologia; apoptose; tensão-oxidativa;
alecrim; medula-óssea, testículo.
SUMMARY
In the present set of investigations, the anti-mutagenic and anti-
cytotoxic effects of aqueous rosemary leaves extract (RE) besides the
dose dependency of these effects, on male mice bone marrow and germ
cells, have been evaluated using in vivo cytogenetic, histopathologic and
apoptotic assays, as well as biochemical analysis. Four different doses
(25, 125, 250 and 375 mg/kg b. wt.) of RE were given through oral
intubation once a day/three days for 15 days prior to DXR administration.
Then, doxorubicin (DXR), a well-known mutagen and cytotoxic agent,
was given at a single dose of 25 mg/kg b. wt. intraperitoneally at the
fifteenth day. The animals of the positive control group (DXR alone)
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showed a significant increase in the mutagenicity in bone marrow cells
with histological damage in the testis accompanied with increased incidence
of apoptotic cells (TUNEL-positive cells), increase in the level of lipid
peroxidation (LPX) and activity of superoxide dismutase (SOD). Though,
the activities of the other antioxidant enzymes such as glutathione
peroxidase (GPX), catalase (CAT) and glutathione reduced form (GSH)
beside the serum level of testosterone and the rate of primary
spermatocytes’ transformation to spermatids were significantly declined
(P< 0.001). The ratio of dismutase to glutathione peroxidase and/or
catalase was significantly elevated. Pretreatment with each dose of RE
resulted in a significant reduction in these adverse changes such as the
frequency of chromosomal aberrations and mitotic index of bone marrow
cells and the level of peroxidation, the ratio of SOD/ GPX or CAT, the
histological damage and the incidence of apoptotic cells in testes. Also, it
caused increase in the levels of some antioxidant enzymes (GSH, CAT
and GPX), and in the level of testosterone and returned the semineferous
tubular cell populations’ ratio to the control picture. The protective efficacy
of the RE was much more pronounced following pretreatment with 125
mg/kg b. wt.
KEY WORDS: doxorubicin; cytogenetic; histopathology; apoptosis; oxidative-stress;
rosemary; bone-marrow; testis
RÉSUMÉ
Cette étude a été faite pour examiner l’effet amélioré de l’utilisation
de l’extrait hydraulique des feuilles du romarin sur le l’empoisonnement
cellulaire, et l’effet bondissant résultant du doxorobissyne sur le tissu de
la moelle épinière et le testicule des rats (males), et le degré de dépendance
de cet effet sur le dosage. L’effet de cet extrait hydraulique a été
expérimenté par l’utilisation de quatre différentes doses prises par la
bouche (25, 125, 250, 375 mg/kg) du poids du corps, pour une période de
15 jours, une seule fois par jour chaque trois jours avant l’injection du
doxorobissyne, puis le doxorobissyne a été injecté au quinzième jour au
péritoine, par une dose qui s’élève à 25 mg/kg du poids du corps, après
deux heures de la dernière dose. L’étude a prouvée l’efficacité de
l’utilisation de l’extrait hydraulique des feuilles du romarin sur
l’amoindrissement des taux de défiguration chromosomiques et la division
mitotique résultant de l’utilisation du doxorobissyne dans la moelle
épinière. Ainsi que l’amélioration des changements cellulaires, la
diminution de la mort programmée et le taux de SOD/ CAF ‘SOD/GPX
aux testicules des rats. Egalement, le traitement a augmenté le taux de la
modification des cellules spermatiques, et l’augmentation de l’hormone
de testostérone, et les taux des enzymes de l’anti-oxydation comme
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CAT’GPX ‘GSF, en les comparant avec les animaux injectés avec le
doxorobissyne seulement. La dose qui s’élève à 125 mg/kg du poids du
corps, était la meilleure dose pour l’amélioration survenue.
MOTS CLÉS: doxorubicine; cytogénétique; hystophatologie; apoptoses; tension-oxidative;
romarin; os-de-la-moelle, testicules
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